Litcius/Paper detail

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Thomas K. Karikari, Tharick A. Pascoal, Nicholas J. Ashton, Shorena Janelidze, Andréa Lessa Benedet, Juan Lantero‐Rodriguez, Mira Chamoun, Mélissa Savard, Min Su Kang, Joseph Therriault, Michael Schöll, Gassan Massarweh, Jean-Paul Soucy, Kina Höglund, Gunnar Brinkmalm, Niklas Mattsson, Sebastian Palmqvist, Serge Gauthier, Erik Stomrud, Henrik Zetterberg, Oskar Hansson, Pedro Rosa‐Neto, Kaj Blennow

2020The Lancet Neurology1,361 citationsDOIOpen Access PDF

Topics & Concepts

MedicineBiomarkerCohortDementiaProspective cohort studyInternal medicineOncologyDiseaseCohort studyCognitive declineFrontotemporal dementiaAlzheimer's diseaseBiochemistryChemistryDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studies
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts | Litcius